Season 9 · Episode 34
S9 Ep34: FDA Approval Insights: Momelotinib in Myelofibrosis With Anemia
OncLive® On Air · OncLive® On Air
October 16, 202312m 0s
Audio is streamed directly from the publisher (audioboom.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr Kuykendall discusses the FDA approval of momelotinib in myelofibrosis with anemia, key data from the MOMENTUM trial, and how momelotinib alters the myelofibrosis treatment paradigm.